Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Tanner

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
Neurology|September 1, 1987
Controlled-release SinemetC G Goetz, C M Tanner, V S Carroll, et al.
Neurology|October 1, 1982
Pergolide mesylate and idiopathic Parkinson diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Neurology|April 1, 1992
Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistanceC L Comella, A S Buchman, C M Tanner, et al.
JAMA|February 3, 1999
Parkinson disease in twins: an etiologic studyC M Tanner, R Ottman, S M Goldman, et al.
Neurology|May 5, 1998
Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's diseaseP Chan, X Jiang, L S Forno, et al.
Clinical Neuropharmacology|October 1, 1989
Hypersexuality with antiparkinsonian therapyR J Uitti, C M Tanner, A H Rajput, et al.
Neurology|September 16, 2005
Occupation and parkinsonism in three movement disorders clinicsS M Goldman, C M Tanner, C W Olanow, et al.
Annals of Neurology|March 1, 1987
Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methodsC G Goetz, C M Tanner, R S Wilson, et al.
Neurology|January 12, 2005
Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohortC Marras, M P McDermott, P A Rochon, et al.
Neurology|February 28, 2002
Smoking and Parkinson's disease in twinsC M Tanner, S M Goldman, D A Aston, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Neurology|September 1, 1987
Controlled-release SinemetC G Goetz, C M Tanner, V S Carroll, et al.
Neurology|October 1, 1982
Pergolide mesylate and idiopathic Parkinson diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Neurology|April 1, 1992
Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistanceC L Comella, A S Buchman, C M Tanner, et al.
JAMA|February 3, 1999
Parkinson disease in twins: an etiologic studyC M Tanner, R Ottman, S M Goldman, et al.
Neurology|May 5, 1998
Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's diseaseP Chan, X Jiang, L S Forno, et al.
Clinical Neuropharmacology|October 1, 1989
Hypersexuality with antiparkinsonian therapyR J Uitti, C M Tanner, A H Rajput, et al.
Neurology|September 16, 2005
Occupation and parkinsonism in three movement disorders clinicsS M Goldman, C M Tanner, C W Olanow, et al.
Annals of Neurology|March 1, 1987
Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methodsC G Goetz, C M Tanner, R S Wilson, et al.
Neurology|January 12, 2005
Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohortC Marras, M P McDermott, P A Rochon, et al.
Neurology|February 28, 2002
Smoking and Parkinson's disease in twinsC M Tanner, S M Goldman, D A Aston, et al.
Pageof 14